Loading…
Neurocysticercosis serodiagnosis: mimotope-based synthetic peptide as potential biomarker
Herein, we evaluate a mimotope-based synthetic peptidenamed NC 4 1 to diagnose neurocysticercosis (NC), a neglected parasitic disease and a major cause of epilepsy worldwide. NC 4 1 synthetic peptide was evaluated to diagnose NC, and total saline extract from Taenia solium metacestodes (SE) was used...
Saved in:
Published in: | Parasitology research (1987) 2019-05, Vol.118 (5), p.1657-1660 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Herein, we evaluate a mimotope-based synthetic peptidenamed NC
4
1 to diagnose neurocysticercosis (NC), a neglected parasitic disease and a major cause of epilepsy worldwide. NC
4
1 synthetic peptide was evaluated to diagnose NC, and total saline extract from
Taenia solium
metacestodes (SE) was used as control. Serum samples from patients with NC (
n
= 40), other parasitic diseases (
n
= 43), and healthy individuals (
n
= 40) were tested. Diagnostic parameters such as sensitivity (Se), specificity (Sp), likelihood ratio (LR), and area under curve (AUC) were calculated using receiver operating characteristic (ROC) curves. The sequence from
T. solium
phosphoenolpyruvate carboxykinase (PEPCK) was used for epitope prediction, resulting in one high-scoring patch centered at residue L247. NC
4
1 synthetic peptide reached high diagnostic performance (Se 97.5% and Sp 97.5%, LR+ 39 and AUC 0.997). Data from diagnostic parameters and in silico analyses proved the usefulness of NC
4
1 synthetic peptide as a diagnostic marker for human NC. |
---|---|
ISSN: | 0932-0113 1432-1955 |
DOI: | 10.1007/s00436-019-06288-9 |